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Janus gold nanostars-mesoporous silica nanoparticles for NIR 
light-triggered drug delivery 
Andy Hernández Montoto,[a] Antoni Llopis-Lorente,[a],[c] Mónica Gorbe,[a],[d] José M. Terrés,[a] Roberto 
Cao-Milán,[e] Borja Díaz de Greñu,[a],[c] María Alfonso,[a],[c] Javier Ibañez,[a] María D. Marcos,[a],[b],[c],[d] Mar 
Orzáez,[d] Reynaldo Villalonga,[f] Ramón Martínez-Máñez[a],[b],[c],[d]* and Félix Sancenón[a],[b],[c],[d] 
 
Abstract: Janus gold nanostars-mesoporous silica nanoparticles 
(AuNSt-MSNs) nanodevices able to release an entrapped payload 
upon irradiation with near infrared (NIR) light are prepared and 
characterized. The AuNSt surface is functionalized with a thiolated 
photolabile molecule (5), whereas the mesoporous silica face is 
loaded with a model drug (doxorubicin) and capped with proton-
responsive benzimidazole--cyclodextrin supramolecular 
gatekeepers (N1). Upon irradiation with NIR-light, the photolabile 
compound 5 is photodissociated, resulting in the formation of 
succinic acid, which induces the opening of the gatekeeper and 
cargo delivery. In the overall mechanism, the gold surface acts as a 
photo-chemical transducer capable of transforming the NIR-light 
input into a chemical messenger (succinic acid) that opens the 
supramolecular nanovalve. The prepared hybrid nanoparticles are 
no cytotoxic to HeLa cells, until they are irradiated with a NIR laser, 
which lead to intracellular doxorubicin release and hyperthermia. 
This induced a remarkable reduction in HeLa cells viability. 
The development of stimuli-responsive gated nanodevices 
based in the use of mesoporous silica has attracted remarkable 
attention due to their potential applications in several research 
fields such as payload controlled release,[1] new 
sensing/recognition protocols,[2] and abiotic communication 
processes.[3,4] These nanodevices are mainly composed by two 
subunits (i) an inorganic mesoporous silica support in which a 
cargo is entrapped and (ii) (supra)molecular entities grafted onto 
the outer surface of the loaded solid.[5,6] The role of the 
(supra)molecular entities is to block the pores inhibiting cargo 
release until an external stimuli is applied. In this field, an 
increasing number of nanodevices have been designed in the 
last years for the selective delivery of selected cargos under 
physical (magnetic fields, ultrasounds, temperature, light, etc) or 
chemical (pH, enzymes, (bio)molecules, etc) stimuli allowing an 
on-command cargo release.[6] 
 One of the most studied applications of these gated 
systems is their use as nanodevices for controlled drug 
delivery.[7-12] Among different stimuli, nanodevices for controlled 
release in response to light irradiation are particularly appealing 
since cargo delivery can be triggered at-will by choosing the 
area and time of irradiation.[13,14] Moreover, the design of 
nanodevices able to release an entrapped drug using near 
infrared (NIR) light have remarkable interest due to the high 
penetration of NIR radiation and minimal damage to tissues.[15-17] 
Reported gated photo-triggered drug delivery systems based in 
these principles include the use of an inorganic porous solid 
(which is loaded with a selected payload) and an stimulus 
transducer which transforms light into a physical or chemical 
signal able to induce the controlled release of the cargo 
entrapped in the carrier. Maximizing the communication between 
these two structural elements is critical for enhancing the 
efficiency of the cargo release. Most of drug photo-triggered 
systems are designed to transform light into heat, where the 
latter is used as communication signal between components.[6] 
Such heat-based communication processes, however, are 
usually inefficient and demand high power irradiances for 
activating cargo release. As a result, the use of such drug photo-
triggered systems may be limited in real biological applications. 
In this context, the development of different mechanisms of 
communication between both structural elements of drug photo-
triggered systems may be appealing. 
 From another point of view, photolabile molecules (PLMs), 
which dissociate upon application of radiation, have been 
extensively used for the preparation of drug delivery 
nanodevices in recent years.[18-20] However, molecular photo-
dissociation requires high energy radiations limiting their use in 
clinical applications.[21-25] In order to overcome these drawbacks, 
low energy radiations can be used for multi-photonic excitation 
of PLMs. This requires the use of high laser powers due to the 
low multiphoton absorbing cross sections of certain 
molecules.[26-29] As an alternative, electric field enhancement 
produced by localized surface plasmon resonance (LSPR) in 
metal nanoparticles has been reported to facilitate multiphoton 
excitation of PLMs even at low power irradiances.[30-32] 
 Taking into account the above mentioned facts, and as a 
proof of concept, we present here new nanodevices based on 
Janus-like nanoparticles[4,33-35] comprising of a gold nanostar 
(AuNSt) as NIR light sensitizer,[36-39] and a gated mesoporous 
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silica nanoparticle (MSNP) as drug carrier. Drug delivery 
involves the use of multi-photonic excitation of a 2-nitrobenzil 
derivative grafted onto the AuNSt at low power irradiance and 
the generation of a “chemical messenger” which is able to 






















Figure 1 Representation of nanodevice N1 based on Janus AuNSt-MSNP 
and NIR light triggered drug delivery mechanism by photo-dissociation of 2-
nitrobenzyl derivative 5. 
 
 The design of the system is depicted in Figure 1. The 
nanodevice (N1) is functionalized with a thiolated 2-nitrobenzil 
derivative (5) on the Au surface whereas the MSNPs are loaded 
with doxorubicin (Dox) and capped with an acid-sensitive 
benzimidazole-β-cyclodextrin gatekeeper.[40] Upon irradiation 
with an 808 nm laser, the AuNSt produce the multiphotonic 
excitation of the photolabile linker with the concomitant cleavage 
and release of succinic acid (chemical messenger). 
Subsequently, succinic acid induces the dethreading of the 
supramolecular nanovalve, due to benzimidazole protonation, 
that result in cargo delivery from the MSNP. The gold surface 
acts as a photo-chemical transducer capable of transforming 
light into a chemical messenger (succinic acid) that triggers 
release from the mesoporous carrier. As far as we know, this 
new strategy for the light-induced delivery of drugs has not yet 
been reported, requires low power irradiances (vide infra) and 
can be used as an alternative to classical systems based in the 
transformation of light into heat. 
 
Figure 2 Synthesis of photolabile molecule 5 bearing a 2-nitrobenzyl linker. 
 
 The thiolated photolabile molecule bearing a 2-nitrobenzyl 
linker coupled with succinic acid (5) was synthesized from 
vanillin in several steps (Figure 2). In a first step, alkylation of 
vanillin with ethyl bromoacetate quantitatively yields the 
aldehyde-ester 1. Then, nitration of compound 1, carried out with 
nitric acid/acetic anhydride, yielded product 2. Afterward, the 
aldehyde moiety in 2 was reduced using sodium borohydride 
yielding benzyl alcohol 3. Subsequent amidation with 
cysteamine produced a 2-nitrobenzyl alcohol derivative bearing 
a thiol group 4, which was coupled with succinic anhydride to 
produce the photolabile molecule 5. The final and intermediate 
products were fully characterized by FT-IR and NMR 
spectroscopies (see Supporting Information). The thermal 
stability of 5 in solution (acetonitrile) was assessed by 1H-NMR 
measurements. At this respect, no spectral changes were 
observed after heating 5 at 70 °C for 30 min.  
 AuNSts were obtained by a seeded growth method using 
polyvinylpyrrolidone (PVP) solution in N,N-dimethylformamide 
(DMF). This procedure is based on the chemical reduction of 
AuCl4
- complexes by DMF, and the subsequent deposition of 
gold atoms in the presence of PVP on the gold nanoparticles, 
acting as seeds.[36,37] Nanostars with size of 120 nm were 
synthesized using seeds (AuNPs) of 15 nm. Absorption 
spectrum of the obtained AuNSts showed a maximum in the NIR 
region at ca. 820 nm (Figure S1). AuNSts were dispersed in a 
solution of compound 5 in THF and finally were washed 
thoroughly to remove unbounded molecules onto nanoparticle´s 
surface. This yielded the intermediate nanoparticles 
AuNSt@PLM-COOH (Figure S2). The absorption of 
AuNSt@PLM-COOH slightly shifted to higher wavelength 
values due to the interaction of the gold surface with the thiol 
group of compound 5 (Figure S1).[37] Hydrodynamic diameter 
and zeta potential measurements by DLS, also confirmed the 
surface modification of AuNSts with 5. The average 
hydrodynamic diameter of nanoparticles changed from 187 for 
AuNSt to 158 nm for AuNSt@PLM-COOH, whereas the zeta 
potential changed from -27.6 to -30.5 mV (see Figure S3). The 
observed reduction in the average hydrodynamic diameter of 
AuNSts, upon functionalization with compound 5, could be 
ascribed to the introduction of ionizable groups. 
 On the other hand, mesoporous silica nanoparticles 
(MSNPs) were prepared by alkaline hydrolysis and subsequent 
condensation of tetraethoxysilane (TEOS) using 
hexadecyltrimethylammonium bromide (CTAB) as a template 
(Figure S4).41 Small angle powder X-ray diffraction (PXRD) 
patterns of MSNPs exhibited three peaks at 2θ = 2.50, 4.23 and 
4.87o, which could be indexed to (100), (110) and (200) 
diffraction planes of a hexagonal unit cell (Figure S5a). 
Moreover, N2 adsorption-desorption isotherms of MSNPs 
showed a Type IV curve. From the curve a pore size of 2.5 nm 
was found, whereas the BET surface area and total pore volume 
were calculated to be 1088 m2 g-1 and 1.05 cm3 g-1, respectively 
(Figure S5b). 
 Afterward, the MSNP´s surface was partially masked by 
confining them at the interface of a water-wax emulsion and then 
functionalized with (3-mercaptopropyl) triethoxysilane (solid HS-
MSNP).[33-35] The paraffin wax was dissolved in hexane and the 
external surface was further functionalized with (3-iodopropyl) 
trimethoxysilane (HS-MSNP-I) and then with benzimidazole (HS-
MSNP-Bzi). Finally, the mesoporous phase was loaded with 
Dox and the pores were capped by the formation of a 
supramolecular complex between the grafted benzimidazole and 
β-cyclodextrin (MSNP@Dox@Bzi-CD).[34] Zeta potential values 
of the nanoparticles, measured by DLS, were used to monitor 
each reaction step (Figure S6). The zeta potentials decreased 
gradually during surface modification with (3-
mercaptopropyl)triethoxysilane (HS-MSNP: -23.4 mV), (3-





iodopropyl)trimethoxysilane (HS-MSNP-I: -33.2 mV)  and 
benzimidazole (HS-MSNP-Bzi: -37.8 mV). Moreover, the zeta 
potential increased from -37.8 to -13.8 mV after Dox loading and 
surface functionalization with β-cyclodextrin (HS-
MSNP@Dox@Bzi-CD). In addition, an overall fraction of organic 
material in HS-MSNP@Dox@Bzi-CD nanoparticles was 
estimated to be 9.5 % by TGA (Figure S7). 
 Finally, AuNSt@PLM-COOH nanoparticles were attached 
to thiol groups on MSNP@Dox@Bzi-CD yielding the final 
nanodevice N1. TEM images (Figures 3a, b and S8) showed the 
mesoporous morphology of the MSNPs and the presence of the 
AuNSts in the Janus colloids. A detailed analysis of nanoparticle 
morphology and composition was carried out using high 
resolution transmission electron microscopy (HR-TEM) and dark 
field scanning transmission electron microscopy (DF-STEM) 
(Figures 3c, d, e and S8, S9, S10). A clear presence of Au, Si 
and C atoms was observed. Moreover, as shown in Figure 3f, 
the UV-visible spectrum of N1 nanodevice presented a marked 
absorption band centered at ca. 810 nm. Small angle powder X-
ray diffraction (PXRD) patterns of N1 nanoparticles exhibited a 
clear peak at 2θ = 2.50o, which could be indexed to (100) 
diffraction plane of a hexagonal unit cell (Figure 3g). In the wide-
angle PXRD pattern, four Au diffraction peaks were clearly 
discerned at 2θ = 38.21, 44.48, 64.76 and 77.74o, which can be 
assigned to (111), (200), (220), and (311) reflections of the face-
centered cubic gold lattice, respectively. Furthermore, the 
average hydrodynamic diameter and the zeta potential of N1 
were found to be 188 nm and -27.5 mV, respectively (Figure 
S11), with good colloidal stability after 24 and 48 h (Figure S12). 
The fraction of organic matter in the Janus nanodevice N1 was 
calculated to be 4.8 % by TGA (Figure S13). 
 
 
Figure 3 (a,b) TEM, (c) HR-TEM and (d) STEM images of the Janus 
nanodevice N1. (d) EDXS element mapping analysis of Au, Si and C from 
STEM image. (Scale Bars: 100 nm (a), 20 nm (b,d,e)). (f) Optical extinction 




Figure 4 (a) Cumulative release of Dox from N1 in the presence (red) and 
absence (black) of NIR light, and from Dox-loaded Janus nanoparticles lacking 
compound 5 (in the AuNSts) in the presence (cyan) and absence (blue) of NIR 
light. (b) Cell viability of HeLa cells in the presence of Janus N1 nanoparticles 
at different concentrations. (c) Cell viability of HeLa cells in the presence of 
Janus N1 (loaded with Dox) and Janus N1empty (without Dox) nanoparticles at 
100 µg mL
-1
 upon 808 nm laser irradiation at different laser power densities for 
10 min. 
 
 NIR light-triggered release experiments in aqueous 
suspensions of N1 (0.1 mg mL-1) were carried out by irradiation 
at 808 nm at low intensity (1 W cm-2) whereas control samples 
were kept in the dark. At scheduled times, samples were 
centrifuged to remove the nanoparticles and the fluorescence 
spectra of released Dox at 555 nm was measured (λexc= 490 
nm). As can be seen in Figure 4a, whereas in the absence of 
irradiation the release of Dox was negligible (black curve), a 
rapid and remarkable delivery was observed (ca. 80% of the 
total Dox delivered after 60 min) when nanoparticles were 
irradiated with NIR light (red curve). During the irradiation, 
compound 5 on AuNSts surface absorbs two low energy 
photons which activates a photo-redox reaction in the aromatic 
ring. This causes the reduction of nitro group and oxidation of 
the benzylic carbon, consequently producing C-O bond cleavage 
and succinic acid formation,[42] as confirmed by control 
experiments (Figures S14-S18). The “chemical messenger” 
succinic acid (pKa1 = 4.21, pKa2 = 5.64) induced protonation of 





benzimidazole (pKa = 5.55) which produced dethreading of the 
benzimidazole-β-CD inclusion complex and Dox delivery. 
Although previous studies have shown the desorption of ligands 
from gold surfaces induced by heat,[43] the temperature of N1 
suspensions upon NIR irradiation (Figure S19) remained 
relatively low (ca. 36 °C and 45 °C at 1 and 3 W cm-2, 
respectively) to be expected to produce derivative 5 direct 
desorption. To verify the proposed mechanism, we performed 
control release experiments with Janus AuNSt-MSNP 
nanoparticles in which the AuNSts were not functionalized with 5. 
The obtained results are shown also in Figure 4a. As could be 
seen, Dox delivery was negligible both, in the absence of 
irradiation (blue curve) or upon irradiation (cyan curve). This 
pointed out the key role played by derivative 5. 
  
 
Figure 5 TEM images of HeLa cells after incubation with Janus N1 
nanoparticles. Scale bars: (a) 5 µm, (c) 2 µm, (b,d) 200 nm. 
 
 As a further step, we evaluated the potential application of 
Janus N1 nanoparticles for light-induce delivery of Dox in cancer 
cells. First, the internalization of N1 nanoparticles in HeLa cells 
was tested using TEM. An efficient nanoparticle uptake by cells 
was produced after their incubation with a N1 suspension in 
DMEM supplemented with 10% FBS. As can be seen in Figure 5, 
Janus N1 nanoparticles were found inside cell endosomes. Next, 
cell viability of N1 was determined using a WST-1 assay after 
incubation with nanoparticles at different concentrations (10, 50 
and 100 g mL-1) for 48 h. The obtained results are shown in 
Figure 4b. Janus N1 nanoparticles show almost no cytotoxicity 
toward HeLa cells in the three concentrations tested, thus 
demonstrating that Dox was efficiently encapsulated inside the 
mesoporous silica phase in N1. Once assessed the non-toxicity 
and the efficient uptake of N1 nanoparticles we carried out NIR 
light triggered in vitro Dox release studies in HeLa cells. In a 
typical experiment, HeLa cells were incubated with N1 or with 
Janus nanoparticles without payload (N1empty) and then 
irradiated with a laser at different power densities. After 
irradiation, cells were further incubated for 48 h and cell viability 
was then evaluated. As could be seen in Figure 4c, the viability 
of HeLa cells treated with N1 and irradiated with NIR light at low 
power density (1 W cm-2) decreased (ca. 30%), whereas viability 
of cells incubated with N1empty remained near 100% after laser 
irradiation at 1 W cm-2. This suggests that decrease in cell 
viability in the presence of N1 upon irradiation at low power 
density is mainly due to Dox release and not to hyperthermia. In 
contrast, viability of cells treated with N1 or N1empty and 
irradiated at high power density (3 W cm-2) decreased 
significantly in both cases, although a larger decrease in cell 
viability was observed for N1 most likely due to a combined 
effect of hyperthermia (Figure S19) and Dox delivery. 
 Finally, NIR light triggered release of Dox from Janus N1 
nanocarriers in HeLa cells was tested using confocal laser 
scanning microscopy. Cells were stained with the DNA-marker 
dye Hoechst 33342 and the intracellular delivery of Dox after 
laser irradiation (power density of 1 W cm-2) was monitored 
(Figure 6a). A negligible Dox fluorescence signal was observed 
in non-irradiated samples. However, a marked 15-fold increase 
of Dox fluorescence in cells was evidenced after laser irradiation, 
corroborating the intracellular cargo release from N1 triggered 
by NIR light (Figure 5b). Besides, the intracellular release of Dox 
from Janus N1 nanoparticles was also triggered by in situ 
irradiation at 633 nm using the confocal laser scanning 
microscope (Figure S20). These results demonstrated the Dox 
release in cells induced by NIR irradiation and attributed to a 
multiphotonic excitation of compound 5 onto AuNSts surface. 
Janus N1 nanoparticles are a suitable platform for combined 




Figure 6 (a) NIR light triggered release of Dox from Janus N1 nanoparticles in 
HeLa cells monitored by confocal laser scanning microscopy. From left to 
right: DNA marker (Hoechst 33342), Dox, and combined (merge) fluorescence 
channels. From top to down: control cells (control), non-irradiated cells after 
incubation with nanoparticles (Janus N1) and NIR light irradiated cells after 
incubation with nanoparticles (Janus N1 + Laser). Scale bars: 100 µm. (b) 
Quantification of the Dox intensity delivered from Janus N1 nanoparticles by 
confocal images analysis. 
 
In conclusion, we reported herein the design, synthesis 
and characterization of a NIR-light responsive delivery system. 
The nanodevice consists of Janus-like nanoparticles with gold 
nanostars and mesoporous silica on opposite sides (AuNSt-
 
   
   



































MSNP). The gold surface is functionalized with 5, a 2-nitrobenzyl 
derivative, whereas the MSNP is loaded with Dox and capped 
with a proton-responsive supramolecular nanovalve. Upon 
application of NIR light, 2-nitrobenzyl derivative molecules on 
the gold surface are dissociated giving succinic acid (chemical 
messenger) that induces the opening of the nanovalve and 
cargo delivery from the mesoporous face. The hybrid 
nanoparticles show no cytotoxicity toward HeLa cells. NIR 
irradiation at low power density (1 W cm-2) resulted in Dox 
delivery and a reduction in cell viability. Moreover, irradiation at 
higher power density (3 W cm-2) induced a larger cell viability 
decrease most likely due to a combined effect of hyperthermia 
and Dox delivery. We hope that this novel strategy for drug 
photodelivery could open new directions toward the 
development of NIR-induced delivery of cytotoxics. Inspired by 
these results, a variety of NIR light-triggered delivery systems 
can be obtained based on Janus AuNSt-MSNP by combining 
other gated ensembles on the MSNP and PLMs as transducer 
molecules on the gold surface. 
Experimental Section 
Synthesis of compound 1. A mixture of vanillin (2.5 g, 16 
mmol), ethyl bromoacetate (2 mL, 3 g, 18 mmol) and sodium 
carbonate (3.5 g, 25 mmol) in DMF (15 mL) was stirred at room 
temperature for 24 h. Water was added, and the mixture was 
partitioned between ethyl acetate and saturated NaCl solution. 
The organic phase was dried with anhydrous Na2SO4 and 
evaporated to yield the aldehyde-ester 1 (3.5 g, 15 mmol, 90 % 
yield) as a white solid (Scheme S1). 1H-NMR (400 MHz, CDCl3) 
δ 9.83 (s, 1H), 7.41 (d, J=1.9, 1H), 7.39 (dd, J=8.1, 1.9, 1H), 
6.86 (d, J=8.1, 1H), 4.75 (s, 2H), 4.24 (q, J=7.1, 2H), 3.92 
(s,3H),1.26 (t, J=7.1,3H); 13C-NMR (100 MHz, CDCl3) δ 190.9, 
168.1, 152.6, 150.1, 131.2, 126.2, 112.5, 110.0, 66.0, 61.7, 56.1, 
14.2. 
Synthesis of compound 2. A solution of aldehyde-ester 1 (3.5 
g, 15 mmol) in acetic anhydride (10 mL) was added to a cooled 
solution of 70 % HNO3 (10 mL) and acetic anhydride (15 mL) at 
0 oC.  The resultant mixture was stirred for 2 h and then allowed 
to warm to room temperature and stirring was continued for an 
additional 4 h. The reaction mixture was poured into a cold water, 
the pH adjusted with solid NaOH to 13-14 and then with 36 % 
HCl to 2-3. The aqueous phase was extracted with EtOAc and 
the organic phase dried and evaporated to yield a yellow solid. 
Recrystallization from MeOH/H2O afforded the product nitro-acid 
2 (3 g, 12 mmol, 80 % yield) (Scheme S1). 1H-NMR (400 MHz, 
CDCl3) δ 10.24 (s, 1H), 7.40 (s, 1H), 7.24 (s, 1H), 4.66 (s, 2H), 
3.86 (s, 3H); 13C-NMR (100 MHz, CDCl3) δ 187.4, 168.9, 153.3, 
150.4, 143.1, 126.0, 110.1, 108.7, 65.6, 56.5. 
Synthesis of compound 3. To a solution of nitro-acid 2 (1 g, 4 
mmol) in THF (20 mL) NaBH4 (0.5 g, 13 mmol) was added at 
room temperature. The reaction mixture was stirred for 24 h. 
Water was added and the pH adjusted with HCl (1M) to 2-3. The 
aqueous phase was extracted with EtOAc and the organic 
phase dried and evaporated to yield a pale yellow solid 3 (0.95 g, 
3.7 mmol, 95 % yield) (Scheme S1). 1H-NMR (400 MHz, 
CO(CD3)2) δ 7.73 (s, 1H), 7.54 (s, 1H), 4.99 (s, 2H), 4.87 (s, 2H), 
4.00 (s, 3H); 13C-NMR (100 MHz, CO(CD3)2) δ 169.8, 155.4, 
146.8, 139.7, 136.0, 111.5, 111.2, 66.5, 61.8, 56.7. 
Synthesis of compound 4. A mixture of solid 3 (0.25 g, 1 
mmol), cysteamine (0.083 g, 1.1 mmol), HOBt (0.145 g, 1.1 
mmol), EDC (0.21 g, 1.1 mmol) and triethylamine (0.15 mL, 0.11 
g, 1.1 mmol) in DMF (5 mL) was stirred for 24 h at room 
temperature. The reaction mixture was partitioned between ethyl 
acetate and saturated NaCl solution. The organic phase was 
dried and evaporated to yield solid 4 (0.24 g, 0.75 mmol, 75 % 
yield) (Scheme S1). 1H-NMR (400 MHz, CO(CD3)2) δ 7.77 (s, 
1H), 7.53 (s, 1H), 4.97 (s, 2H), 4.63 (s, 2H), 4.00 (s, 3H), 3.62 
(dd, J=13.2, 6.7, 2H), 2.92 (t, J=6.7, 2H); 13C-NMR (100 MHz, 
CO(CD3)2) δ 168.5, 155.5, 146.5, 136.5, 126.1, 112.6, 111.1, 
70.0, 68.1, 56.8, 38.9, 38.7. 
Synthesis of compound 5. A mixture of alcohol 4 (0.24 g, 0.75 
mmol), succinic anhydride (0.083 g, 0.83 mmol) and DMAP (0.1 
g, 0.83 mmol) in THF (5 mL) was stirred for 24 h at room 
temperature. Water was added, and the pH adjusted with HCl 
(1M) to 2-3. The aqueous phase was extracted with EtOAc and 
the organic phase dried and evaporated to yield a solid 5 (0.22 g, 
0.53 mmol, 70 % yield) (Scheme S1). 1H-NMR (400 MHz, 
CO(CD3)2) δ 7.79 (s, 1H), 7.24 (s, 1H), 5.49 (s, 2H), 4.66 (s, 2H), 
4.02 (s, 3H), 3.62 (dd, J=12.7, 6.5, 2H), 2.92 (t, J=6.5, 2H), 2.75 
(m, 2H), 2.68 (m, 2H); 13C-NMR (100 MHz, CO(CD3)2) δ 174.0, 
172.7, 168.6, 155.4, 147.2, 140.4, 129.8, 112.6, 111.6, 69.7, 
63.5, 57.1, 38.9, 38.8, 30.7, 30.6. 
Synthesis of gold nanostars (AuNSts). Gold nanostars were 
synthesized by seeded growth method using PVP solution in 
DMF. At 25 oC, 50 μL of an aqueous solution of 166 mM HAuCl4 
was mixed with 15 mL of 20 mM PVP solution in DMF. After 5 
min, 10 μL of preformed seed dispersion (15 nm gold 
nanospheres coated with PVP in ethanol, [Au] = 6.5 mM) was 
added and allowed to react for 24 hours without stirring. Gold 
nanoparticles were recovered by centrifugation (20 min, 9500 
rpm) and washed five times with water by centrifugation and 
redispersion. The concentration of Au in all gold colloids was 
derived from their extinction spectra (absorbance at 400 nm).  
Synthesis of mesoporous silica nanoparticles (MSNP). 1.0 g 
(2.74 mmol) of CTAB was dissolved in 480 mL of deionized 
water. Then, the pH was increased by adding 3.5 mL of a 2 M 
NaOH solution and the temperature was increased to 80 °C. 
TEOS (5.0 mL, 22.4 mmol) was then added dropwise to this 
solution. Magnetic stirring was kept for 2 h to give a white 
precipitate. Finally, the solid was isolated by centrifugation, 
washed several times with water and dried at 60 °C overnight. 
To obtain the final mesoporous nanoparticles (MSNP), the as-
synthesized solid was calcined at 550 oC using an oxidant 
atmosphere for 5 h in order to remove the surfactant. 
Synthesis of Janus N1 nanoparticles. MSNP (180 mg) were 
dispersed in 9 mL of aqueous solution (6.7 % ethanol) and 
CTAB was added for a 1 µM final concentration. The mixture 
was heated at 75 °C, and then 1 g of paraffin wax was added. 
Once the paraffin was melted, the mixture was vigorously stirred 
for 15 minutes using an Ultra-Turrax T-8 homogenizer (IKA). 
Afterward, the mixture was further stirred for 1 h at 1500 rpm 
and 75 °C using a magnetic stirrer. The resulting Pickering 
emulsion was then cooled to room temperature, diluted with 9 
mL of methanol and reacted with 180 µL of (3-
mercaptopropyl)triethoxysilane for 3 h. The solid (HS-MSNP) 
was collected by centrifugation, washed with hexane and finally 
dried at 60 °C overnight. The partially mercapto-functionalized 
MSNP (HS-MSNP, 10 mg) were dispersed in 1.5 mL of 
acetonitrile, followed by the addition of 50 μL of (3-
iodopropyl)trimethoxysilane. The solution was stirred at 25 oC for 
18 h. The iodopropyl-modified MSNP (HS-MSNP-I) were 
collected via centrifugation and washed with ACN. Then, the 
nanoparticles were re-suspended in 1.5 mL of anhydrous DMF, 





in which 20 mg of benzimidazole and 20 μL of triethylamine 
were added. The solution was stirred at 70 oC for 24 h. The 
nanoparticles (HS-MSNP-Bzi) were collected via centrifugation 
and washed with DMF and H2O. The nanoparticles were mixed 
with 1.5 mL of Dox in aqueous solution (2 mg mL-1). The 
suspension was stirred for 18 h before β-cyclodextrin (40 mg) 
was added. The mixture was stirred for another 18 h, and the 
nanoparticles (HS-MCM@Dox@Bzi-CD) were centrifuged and 
washed with H2O. For gold attachment, AuNSts were dispersed 
in 2 mL of compound 6 solution in THF and stirred for 18 h. 
AuNSt@PLM-COOH nanoparticles were collected by 
centrifugation, washed with THF and re-dispersed in H2O. HS-
MCM@Dox@Bzi-CD nanoparticles were dispersed in 0.5 mL of 
H2O and added over 1.5 mL of the AuNSt@PLM-COOH 
suspension in H2O. The mixture was stirred overnight, collected 
by centrifugation, washed with H2O and dried. 
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